Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 16, 2015 |
| Target | Takeda Pharmaceutical Company - Core Respiratory Business |
| Sector | Life Science |
| Buyer(s) | AstraZeneca |
| Sellers(s) | Takeda |
| Deal Type | Divestiture |
| Deal Value | 575M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Life Science |
| Employees | 83,100 |
| Revenue | 54.1B USD (2024) |
AstraZeneca is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in several major disease areas, including oncology, cardiovascular, renal & metabolism, and respiratory & immunology. AstraZeneca was founded in 1992 and is based in Cambridge, United Kingdom.
| Deal Context for Buyer | # |
|---|---|
| Overall | 11 of 23 |
| Sector: Life Science | 9 of 21 |
| Type: Divestiture | 3 of 6 |
| Country: Japan | 1 of 1 |
| Year: 2015 | 2 of 3 |
| Size (of disclosed) | 13 of 19 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-11-05 |
ZS Pharma
Coppell, Texas, United States ZS Pharma, founded in 2008, is a privately held specialty pharmaceutical company based in Coppell, Texas and Menlo Park, CA. Our core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. |
Buy | $2.7B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-17 |
Acerta Pharma BV
Oss, Netherlands Acerta Pharma is a cancer drug developer with operations in the Netherlands and in California. |
Buy | $4.0B |
| Category | Company |
|---|---|
| Founded | 1781 |
| Sector | Life Science |
| Employees | 47,455 |
| Revenue | 4.58T JPY (2025) |
Takeda is a global biopharmaceutical organization committed to improving the health and well-being of people worldwide. Takeda is dedicated to addressing unmet medical needs through the development of innovative and transformative therapies. The Company's diverse portfolio encompasses a wide range of therapeutic areas, including oncology, gastroenterology, rare diseases, neuroscience, and vaccines. Takeda was established in 1781 and is based in Tokyo, Japan.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 7 |
| Sector: Life Science | 1 of 3 |
| Type: Divestiture | 1 of 7 |
| Country: Japan | 1 of 6 |
| Year: 2015 | 1 of 1 |
| Size (of disclosed) | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-05-08 |
Inviragen
Fort Collins, Colorado, United States Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. |
Buy | $35M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-05 |
Baxalta - Biologics Manufacturing Facility
Brooklyn Park, Minnesota, United States Baxalta - Biologics Manufacturing Facility is a producer of Entyvio® (vedolizumab) and other biologic products. |
Buy | - |
